Naveen Yarlagadda

Naveen Yarlagadda

University of Arkansas for Medical Sciences - Little Rock / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4848307
person_outline Naveen Yarlagadda's MOST POPULAR ARTICLES
1-) Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma OncoTargets and therapy, 7095-7107, 2018
2-) High-dose interleukin-2 therapy for metastatic renal cell carcinoma: a contemporary experience Urology 83 (5), 1129-1134, 2014
3-) Genomic analysis of primary plasma cell leukemia reveals complex structural alterations and high-risk mutational patterns Blood cancer journal 10 (6), 70, 2020
4-) Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myeloma Blood advances 6 (3), 808-817, 2022
5-) Immunotherapy outcomes in advanced melanoma in relation to age The Permanente Journal 24, 19.093, 2020